GLASS LAB · Medical Aesthetics Evidence Index 303 cells · 19,226 papers · 5,969 top-tier evidence

Pigment · Solar lentigo / sunspot

Nonablative fractional resurfacing evidence for Solar lentigo / sunspot

C 44.0 / 100 Supported 1 RCT/meta · 1 clinical/observational · 2 case · 6 total
Early-stage evidence

This is an early evidence stage based mainly on observational studies and case reports. Use it as supplementary reference, and follow your doctor's judgment for treatment decisions.

Grade combines the quantity and quality of the research, while direction is a separate signal showing how the papers assess effectiveness.

Median year 2020 Last 5 years 33% Positive results 67%

Known in Korea as

라셈드MOXI헤일로 레이저

Procedure and brand names vary, but the evidence above applies to the same procedure mechanism.

Key papers

tier1 Tripeptide and hexapeptide topical as adjunct to nonablative fractional resurfacing for photodamage: A randomized split-face trial. Journal of cosmetic dermatology · 2020 · PMID 33051975

Abstract summary (English) BACKGROUND: Topical adjuncts have been investigated to improve clinical outcomes associated with laser resurfacing for photodamage and cutaneous aging. One such product is a tripeptide/hexapeptide serum, which has been shown to increase dermal collagen and elastin as well as improve postprocedural recovery following treatments. AIMS: A randomized, blinded, split-face, comparative trial was performed to assess the...

Journal Article, Randomized Controlled Trial

View on PubMed
tier2 1,927-nm fractional thulium fiber laser for the treatment of nonfacial photodamage: a pilot study. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2011 · PMID 21342312

Abstract summary (English) BACKGROUND: A 1,927-nm wavelength was recently added to the 1,550-nm erbium-doped fiber laser. This wavelength possesses a higher absorption coefficient for water than the 1,550-nm, conferring greater ability to target epidermal processes. OBJECTIVE: To evaluate the efficacy and safety of a novel 1,927-nm fractional thulium fiber laser in the treatment of nonfacial photodamage.

Evaluation Study, Journal Article

View on PubMed
tier3 Investigating the efficacy of a fractionated 1927 nm laser for diffuse dyspigmentation and actinic changes. Lasers in surgery and medicine · 2023 · PMID 36950878

Abstract summary (English) OBJECTIVES: Facial actinic irregularities are frequent targets for noninvasive, energy-based treatment. These irregularities are multifactorial and driven by both intrinsic factors such as aging, genetics, and hormone exposure, and extrinsic factors, such as UV exposure. Clinically, this photodamage manifests as dyschromic skin disorders like melasma and actinic features such as solar lentigines.

Case Reports, Research Support, Non-U.S. Gov't, Journal Article

View on PubMed
tier3 Rejuvenation of the male scalp using 1,927 nm non-ablative fractional thulium fiber laser. Lasers in surgery and medicine · 2017 · PMID 28117489

Abstract summary (English) OBJECTIVE: The male scalp undergoes extensive photodamage due to a high prevalence of androgenic alopecia and exposure to ultraviolet radiation. This photodamage presents as solar lentigines, fine rhytides, and keratosis, and can prematurely age a patient. In this study, we demonstrate the safety and efficacy of the fractionated 1,927 nm thulium fiber laser using high density and high energy settings to achieve...

Case Reports, Journal Article

View on PubMed
tier_other Optimizing Outcomes With the 1550/1927 nm Dual Wavelength Non-Ablative Fractional Laser: Experienced User Recommendations. Journal of drugs in dermatology : JDD · 2021 · PMID 34784135

Abstract summary (English) BACKGROUND: Fractional laser treatment was introduced in 2004 as a non-invasive technique to treat sun-damaged and aging skin. Since then, numerous ablative and non-ablative photothermolysis technologies and devices have been introduced, increasing the options for clinicians and patients but also increasing the complexity regarding which system to use and the techniques to optimize outcomes. No two devices are the...

Journal Article

View on PubMed
tier_other Q-Switched Alexandrite Laser-induced Chrysiasis. The Journal of clinical and aesthetic dermatology · 2015 · PMID 26430491

Abstract summary (English) BACKGROUND: Chyriasis is an uncommon side effect that occurs in patients who are receiving prolonged treatment with either intravenous or intramuscular gold as a distinctive blue-gray pigmentation of light-exposed skin. Laser-induced chrysiasis is a rarely described phenomenon in individuals who have received systemic gold and are subsequently treated with a Q-switched laser. PURPOSE: To describe the characteristics...

Journal Article

View on PubMed

Suggested interpretation

Limited evidence

Personalized evidence report

Tell us more about your concern
and the Glass Lab bot will build a personalized report for you.

Based on the Nonablative fractional resurfacing · Solar lentigo / sunspot information on this page, we'll email you an evidence summary tailored to your skin condition and treatment stage.

Concerns of interest (select multiple)
Decision stage
← Other indications for the same procedure group  |  Other procedures for the same indication →